药品注册申请号:020551
申请类型:NDA (新药申请)
申请人:ABBVIE
申请人全名:ABBVIE INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 NIMBEX CISATRACURIUM BESYLATE INJECTABLE;INJECTION EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No AP 1995/12/15 1995/12/15 Discontinued
002 NIMBEX PRESERVATIVE FREE CISATRACURIUM BESYLATE INJECTABLE;INJECTION EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No AP 1995/12/15 Discontinued
003 NIMBEX PRESERVATIVE FREE CISATRACURIUM BESYLATE INJECTABLE;INJECTION EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No AP 1995/12/15 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
审批日期提交号审批结论提交分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
1995/12/15 ORIG-1(原始申请) Approval Type 2 - New Active Ingredient STANDARD
>>>补充申请<<<
审批日期提交号审批结论补充类别或审批类型审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2022/10/14 SUPPL-28(补充) Approval Labeling-Package Insert STANDARD
2022/10/07 SUPPL-29(补充) Approval Labeling-Package Insert STANDARD
2018/07/26 SUPPL-26(补充) Approval Labeling-Container/Carton Labels STANDARD
2018/07/26 SUPPL-20(补充) Approval Labeling-Package Insert STANDARD
2013/04/01 SUPPL-23(补充) Approval Manufacturing (CMC) STANDARD
2010/11/22 SUPPL-19(补充) Approval Labeling 901 REQUIRED
2010/06/02 SUPPL-17(补充) Approval Labeling-Container/Carton Labels STANDARD
2003/07/18 SUPPL-9(补充) Approval Efficacy-Labeling Change With Clinical Data STANDARD
2002/10/15 SUPPL-11(补充) Approval Manufacturing (CMC) STANDARD
2002/06/04 SUPPL-10(补充) Approval Manufacturing (CMC) STANDARD
2000/02/25 SUPPL-8(补充) Approval Labeling STANDARD
2000/02/25 SUPPL-7(补充) Approval Labeling STANDARD
1999/05/21 SUPPL-5(补充) Approval Labeling STANDARD
1999/05/21 SUPPL-4(补充) Approval Labeling STANDARD
1999/03/26 SUPPL-6(补充) Approval Manufacturing (CMC)-Control STANDARD
1998/10/15 SUPPL-3(补充) Approval Efficacy-Labeling Change With Clinical Data STANDARD
1998/06/19 SUPPL-2(补充) Approval Labeling STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
001 5453510 2012/09/26 U-127 PDF格式**本条是由Drugfuture回溯的历史信息**
002 5453510 2012/09/26 U-127 PDF格式**本条是由Drugfuture回溯的历史信息**
003 5453510 2012/09/26 U-127 PDF格式**本条是由Drugfuture回溯的历史信息**
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
>>>活性成分:CISATRACURIUM BESYLATE; 剂型/给药途径:INJECTABLE;INJECTION; 规格:EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 治疗等效代码:AP<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
020551 001 NDA NIMBEX CISATRACURIUM BESYLATE INJECTABLE;INJECTION EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Discontinued Yes No AP 1995/12/15 ABBVIE
020551 003 NDA NIMBEX PRESERVATIVE FREE CISATRACURIUM BESYLATE INJECTABLE;INJECTION EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Discontinued Yes No AP 1995/12/15 ABBVIE
>>>活性成分:CISATRACURIUM BESYLATE; 剂型/给药途径:INJECTABLE;INJECTION; 规格:EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 治疗等效代码:AP<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
020551 002 NDA NIMBEX PRESERVATIVE FREE CISATRACURIUM BESYLATE INJECTABLE;INJECTION EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Discontinued Yes No AP 1995/12/15 ABBVIE
>>>活性成分:CISATRACURIUM BESYLATE; 剂型/给药途径:INJECTABLE;INJECTION; 规格:EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 治疗等效代码:AP<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
020551 001 NDA NIMBEX CISATRACURIUM BESYLATE INJECTABLE;INJECTION EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Discontinued Yes No AP 1995/12/15 ABBVIE
020551 003 NDA NIMBEX PRESERVATIVE FREE CISATRACURIUM BESYLATE INJECTABLE;INJECTION EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Discontinued Yes No AP 1995/12/15 ABBVIE
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2025 DrugFuture->U.S. FDA Drugs Database